A mutator phenotype in cancer

Cancer Research

Volumn 61, Issue 8, 2001, Pages 3230-3239

  Loeb, L A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CANCER CELL; CANCER GENETICS; CANCER PREVENTION; EARLY DIAGNOSIS; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC STABILITY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; MUTATION RATE; MUTATOR GENE; PHENOTYPE; PRIORITY JOURNAL; TECHNOLOGY; TUMOR GROWTH;

ANIMALS; HUMANS; MUTATION; NEOPLASMS; PHENOTYPE;

EID: 0035870243     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (101)

1. Errors in DNA replication as a basis of malignant change
2. My personal thoughts on the recent joint U. S./Japan cancer meeting in Honolulu, Hawaii
3. Mutator phenotype may be required for multistage carcinogenesis
4. Microsatellite instability: Marker of a mutator phenotype in cancer
5. Genomic instability and tumor progression: Mechanistic considerations
6. Mutagenic DNA polymerase
7. Xeroderma pigmentosum
8. Chromosome instability syndromes: Lessons for carcinogenesis
9. The clonal evolution of tumor cell populations
10. The spontaneous azaguanine-resistant mutants of diploid human fibroblasts
11. DNA repair in an active gene: Removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall
12. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene
13. The mutation rate and cancer
14. The age distribution of cancer and a multi-stage theory of carcinogenesis
15. How many mutations are required for tumorigenesis? Implications from human cancer data
16. The molecular basis of oncogenes and tumor suppressor genes
17. DNA copy number losses in human neoplasms
18. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization
19. Genetic analysis of benign, low-grade, and high-grade ovarian tumors
20. DNA copy number changes in development and progression in leiomyosarcomas of soft tissues
21. Minimal sizes of deletions detected by comparative genomic hybridization
22. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells
23. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas
24. On the origin of multiple mutations in human cancers
25. Genetic instability in colorectal cancers
26. A checkpoint on the road to cancer
27. Significance of multiple mutations in cancer
28. Genetic instability of cancer cells is proportional to their degree of aneuploidy
29. Aneuploidy vs. gene mutation hypothesis of cancer: Recent study claims mutation but is found to support aneuploidy
30. The DNA sequence of human chromosome 21
31. Risks of leukaemia and solid tumours in individuals with Down's syndrome
32. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus
33. Evolution of neoplastic cell lineages in Barrett oesophagus
34. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis
35. Isolation and characterization of allelic loss and gains in colorectal tumors by arbitrarily primed polymerase chain reaction
36. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
37. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis
38. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
39. The onset and extent of genomic instability in sporadic colorectal tumor progression
40. Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers
41. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability
42. Induction of microsatellite instability by oxidative DNA damage
43. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer
44. The role of mismatch repair in the prevention of base pair mutations in Saccharomyces cerevisiae
45. Induction of microsatellite mutations by oxidative agents in human lung cancer cell lines
46. Silent and multiple mutations in p53 and the question of the hypermutability of tumors
47. Somatic point mutations in the p53 gene of human tumors and cell lines: Updated compilation
48. APC mutations in colorectal tumors with mismatch repair deficiency
49. Somatic microsatellite mutations as molecular tumor clocks
50. Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours
51. Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog
52. Genetic alterations during colorectal-tumor development
53. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: An implication for mutator phenotype and breast cancer pathogenesis
54. Creation of human tumour cells with defined genetic elements
55. The origin of genetic information: Viruses as models
56. Lethal mutagenesis of HIV with mutagenic nucleoside analogs
57. Errors in DNA synthesis: A source of spontaneous mutations
58. Quality control by DNA repair
59. DNA oxidation matters: The HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxoguanine
60. Apurinic sites as common intermediates in mutagenesis
61. Endogenous lesions, S-phase-independent spontaneous mutations and evolutionary strategies for base excision repair
62. Transcription-coupled DNA repair
63. Mammalian DNA mismatch repair
64. DNA polymerase β mutations in human colorectal cancer
65. DNA polymerase β gene mutation in human prostate cancer
66. DNA polymerase β gene mutations in human bladder cancer
67. 2C is an error-prone DNA polymerase, Escherichia coli pol V
68. Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity
69. hRAD30 mutations in the variant form of xeroderma pigmentosum
70. Novel DNA polymerases offer clues to the molecular basis of mutagenesis
71. DNA helicases in inherited human disorders
72. Positional cloning of the Wemer's syndrome gene
73. The Wemer syndrome gene. The molecular basis of RecQ helicase-deficiency diseases
74. The Bloom's syndrome gene product is homologous to RecQ helicases
75. Increased frequency of 6-thioguanine-resistant peripheral blood lymphocytes in Werner syndrome patients
76. Human breast cancer cells contain an error-prone DNA replication apparatus
77. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
78. p53: At the crossroads of molecular carcinogenesis and cancer risk assessment
79. p53, the cellular gatekeeper for growth and division
80. Proliferation of mutators in a cell population
81. Direct selection for mutators in Escherichia coli
82. Transient expression of a mutator phenotype in cancer cells
83. Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts
84. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers
85. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
86. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53
87. Frequent clones of p53-mutated keratinocytes in normal human skin
88. Genetic imbalances in precursor lesions of endometrial cancer detected by comparative genomic hybridization
89. Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis
90. Detection of bladder cancer recurrence by microsatellite analysis of urine
91. Genetic alterations in bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer
92. Molecular epidemiology of human cancer: Contribution of mutation spectra studies of tumor suppressor genes
93. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer-prone chronic inflammatory disease
94. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis
95. 6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors
96. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa
97. Increased formation of oxidative DNA damage, 8-hydroxyguanosine, in human livers with chronic hepatitis
98. Association between reactive oxygen species and disease activity in chronic hepatitis C
99. Flow cytometric assay of DNA damage by alkaline unwinding coupled with DNA repair endonucleases
100. Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis